MD Anderson is pleased to offer online learning opportunities for physicians and health care providers. These online CME programs range from communication skills to the latest advances in the field of oncology and come with specific instructions for completion and obtaining credit.
Emerging Therapeutic Strategies for Relapse and Refractory Multiple Myeloma: Highlights from ASH 2018
This enduring panel discussion will review the efficacy and safety of emerging treatment options for patients with RRMM and discuss the clinical practice implications of these therapies in the context of currently approved therapies and treatment algorithms. This activity will also address practical strategies to individualize RRMM treatment paradigms, while considering both approved and investigational strategies, and accounting for patient-specific factors.
Optimizing the Use of Targeted Therapies into CLL Treatment Paradigms: Applying the Latest Evidence into Practice
This interactive activity features 2 leading experts in CLL who discuss and debate the latest advances regarding novel and emerging targeted therapies for patients with CLL, as well as discuss the evolving role of prognostic molecular biomarkers in targeted therapy initiation and treatment selection, highlighting key data presented at the 2018 Annual Meeting and Exposition of the American Society of Hematology (ASH).
Evolving Considerations in Immuno-Oncology: Bridging the Gaps Between Research and Clinical Care Program E117651
The goal of this international, on-demand web portal is to inform oncology HCPs on the clinical rationale of checkpoint inhibitor (CPI) use across various cancers; the latest efficacy and safety data that may inform patient selection; practical strategies for effective CPI use and the management of treatment-related adverse events; and potential region-specific variations in CPI clinical utility.